By understanding the rampant infections of Mycobacterium tuberculosis (Mtb) and inflammations caused due to the generation of radical species during the Mtb infection, a series of (E)-2-(2-allylidenehydrazinyl)thiazole derivatives, with dual-action properties, was designed. The molecules were designed with a considerable variation in LogP, one of the critical parameters in physicochemical properties, and analyzed for their drug-likeness. For the synthesis, a simple, green, and multicomponent one-pot synthesis method was developed. The in vitro inhibition potentials were evaluated against Mtb H37 Rv by the microplate Alamar Blue assay. The results reveal that compound 6 was potent, with a MIC value of 6.5 µg/ml, and showed better interactions with the KasA protein with binding free energy (ΔG) of -9.4 kcal/mol. Also, the radical scavenging properties were studied to establish the dual-action properties of the molecules. Compound 9 exhibited promising antioxidant and nitric oxide radical scavenging activities, with 81.7% and 81.0%, respectively, at 1,000-μg/ml concentration.

Chemical Science Research Group Advanced Research Group Division of Research and Development Lovely Professional University Phagwara Punjab India

Organic Chemistry Research Laboratory School of Chemical Sciences Solapur University Solapur Maharashtra India

Protein DNA Interaction Group Central European Institute of Technology Brno Czech Republic

Zobrazit více v PubMed

H. Herzog, Respiration 1998, 65, 5.

T. Zajaczkowski, Cent. Eur. J. Urol. 2012, 65, 182.

WHO global tuberculosis report 2019, in, World Health Organization, Geneva, Switzerland 2019.

(a) A. Faustini, A. J. Hall, C. A. Perucci, Thorax 2006, 61, 158

(b) A. Fraser, M. Paul, A. Attamna, L. Leibovici, Int. J. Tuberc. Lung Dis. 2005, 10, 19

(c) M. Zignol, M. S. Hosseini, A. Wright, C. L. V. Weezenbeek, P. Nunn, C. J. Watt, B. G. Williams, C. Dye, J. Infect. Dis. 2006, 194, 479.

R. Gravier-Hernández, L. Gil-del Valle, in HIV/AIDS (Eds: V. R. Preedy, R. R. Watson), Academic Press, Tucson, AZ, USA 2018, pp. 17-27.

G. S. Palanisamy, N. M. Kirk, D. F. Ackart, C. A. Shanley, I. M. Orme, R. J. Basaraba, PLOS One 2011, 6, e26254.

M. H. Shaikh, D. D. Subhedar, M. Arkile, V. M. Khedkar, N. Jadhav, D. Sarkar, B. B. Shingate, Bioorg. Med. Chem. Lett. 2016, 26, 561.

S. S. Talhar, P. S. Ambulkar, B. R. Sontakke, P. J. Waghmare, M. R. Shende, A. K. Pal, P. Narang, Indian J. Tuberc. 2019, 66, 227.

I. Wiid, T. Seaman, E. Hoal, A. Benade, P. D. van Helden, IUBMB Life 2004, 56, 101.

K. Nanashima, T. Mawatari, N. Tahara, N. Higuchi, A. Nakaura, T. Inamine, S. Kondo, K. Yanagihara, K. Fukushima, N. Suyama, S. Kohno, K. Tsukamoto, Tuberculosis 2012, 92, 253.

(a) A. Song, H. Yu, C. Wang, X. Zhu, K. Liu, X. Ma, Curr. Pharm. Des. 2015, 21, 950

(b) B. Meunier, Acc. Chem. Res. 2008, 41, 69

(c) M. R. Felício, O. N. Silva, S. Gonçalves, N. C. Santos, O. L. Franco, Front. Chem. 2017, 5, 5

(d) D. Sun, Y. Zhao, S. Zhang, L. Zhang, B. Liu, L. Ouyang, Eur. J. Med. Chem. 2020, 188, 112025.

J. S. Carter, S. Kramer, J. J. Talley, T. Penning, P. Collins, M. J. Graneto, K. Seibert, C. M. Koboldt, J. Masferrer, B. Zweifel, Bioorg. Med. Chem. Lett. 1999, 9, 1171.

E. Gürsoy, N. U. Güzeldemirci, Eur. J. Med. Chem. 2007, 42, 320.

M. A. Metwally, E. Abdel-Latif, F. A. Amer, G. Kaupp, J. Sulfur Chem. 2004, 25, 63.

R. N. Sharma, F. P. Xavier, K. K. Vasu, S. C. Chaturvedi, S. S. Pancholi, J. Enzyme Inhib. Med. Chem. 2009, 24, 890.

N. Swarnagowri, L. G. Santhosh, Mini-Rev. Med. Chem. 2019, 19, 215.

N. Ergenç, G. Çapan, N. S. Günay, S. Özkirimli, M. Güngör, S. Özbey, E. Kendi, Arch. Pharm. 1999, 332, 343.

J. C. Jaen, L. D. Wise, B. W. Caprathe, H. Tecle, S. Bergmeier, C. C. Humblet, T. G. Heffner, L. T. Meltzer, T. A. Pugsley, J. Med. Chem. 1990, 33, 311.

N. U. Güzeldemirci, Ö. Küçükbasmacı, Eur. J. Med. Chem. 2010, 45, 63.

P. Makam, T. Kannan, Eur. J. Med. Chem. 2014, 87, 643.

E. Vitaku, D. T. Smith, J. T. Njardarson, J. Med. Chem. 2014, 57, 10257.

(a) D. Das, P. Sikdar, M. Bairagi, Eur. J. Med. Chem. 2016, 109, 89

(b) M. E. Khalifa, Acta Chimica Slovenica 2018, 65, 1.

(a) S. Rollas, S. Küçükgüzel, Molecules 2007, 12, 1910

(b) V. J. Negi, A. K. Sharma, J. S. Negi, V. Ram, Int. J. Pharm. Chem. 2013, 2, 100

(c) M. Singh, N. Raghav, Int. J. Pharm. Pharm. Sci. 2011, 3, 26

(d) M. Asif, Int. J. Chem. Appl. Biol. Sci. 2014, 1, 23

(e) K. Pradeep, N. Balasubramanian, Mini-Rev. Med. Chem. 2013, 13, 971

(f) Ł. Popiołek, Med. Chem. Res. 2017, 26, 287

(g) J. Pandey, R. Pal, A. Dwivedi, K. Hajela, Arzneim.-Forsch 2002, 52, 39

(h) A. Kajal, S. Bala, N. Sharma, S. Kamboj, V. Saini, Int. J. Med. Chem. 2014, 2014, 11.

M. Bijo, S. Jerad, J. A. Mohamed, E. M. Githa, U. Dhasthakeer, N. S. S. Puthucode, F. S. Kallivalappil, M. Srinubabu, Infect. Disord.: Drug Targets 2015, 15, 76.

(a) P. Makam, R. Kankanala, A. Prakash, T. Kannan, Eur. J. Med. Chem. 2013, 69, 564

(b) A. Arshad, H. Osman, M. C. Bagley, C. K. Lam, S. Mohamad, A. S. Zahariluddin, Eur. J. Med. Chem 2011, 46, 3788

(c) G. Turan-Zitouni, Z. A. Kaplancikli, A. Ozdemir, Eur. J. Med. Chem. 2010, 45, 2085.

K. Naumann, J. Prakt. Chem. 1999, 341, 417.

(a) M. P. Gleeson, A. Hersey, D. Montanari, J. Overington, Nat. Rev. Drug. Discovery 2011, 10, 197

(b) S. Khojasteh, H. Wong, C. C. A. Hop, in Drug Metabolism and Pharmacokinetics Quick Guide, Springer, New York, NY 2011, pp. 165-181

(c) S. B. Bunally, C. N. Luscombe, R. J. Young, SLAS Discovery 2019, 24, 791.

(a) C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3

(b) C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 2001, 46, 3.

I. Kola, J. Landis, Nat. Rev. Drug Discovery 2004, 3, 711.

D. F. Veber, S. R. Johnson, H.-Y. Cheng, B. R. Smith, K. W. Ward, K. D. Kopple, J. Med. Chem. 2002, 45, 2615.

P. D. Leeson, A. M. Davis, J. Med. Chem. 2004, 47, 6338.

(a) P. D. Leeson, B. Springthorpe, Nat. Rev. Drug Discovery 2007, 6, 881

(b) P. D. Leeson, S. A. St-Gallay, M. C. Wenlock, Med. Chem. Commun. 2011, 2, 91.

(a) B. Testa, P. Crivori, M. Reist, P.-A. Carrupt, Perspect. Drug Discovery 2000, 19, 179

(b) M. J. Waring, Bioorg. Med. Chem. Lett. 2009, 19, 2844

(c) J. A. Arnott, S. L. Planey, Expert Opin. Drug Discovery 2012, 7, 863.

B. Testa, P. Crivori, M. Reist, P.-A. Carrupt, Perspect. Drug Discovery Des. 2000, 19, 179.

(a) M. J. Waring, Expert Opin. Drug Discovery 2010, 5, 235

(b) S. Lobo, Expert Opin. Drug Discovery 2019, 1.

(a) D. K. Vikas, N. N. Dinesh, G. H. Mahesh, G. R. Dattatraya, B. B. Raghunath, Lett. Org. Chem. 2020, 17, 61

(b) V. D. Kadu, M. G. Hublikar, D. G. Raut, R. B. Bhosale, Asian J. Chem. 2019, 31, 1189

(c) D. G. Raut, R. B. Bhosale, J. Sulfur Chem. 2018, 39, 1

(d) H. Mahesh, D. Prashant, K. Vikas, S. Sachin, R. Dattatraya, B. Raghunath, J. Shravan, Asian J. Pharm. Clin. Res. 2019, 377, 12

(e) G. R. Dattatraya, B. P. Sandeep, D. K. Vikas, G. H. Mahesh, B. B. Raghunath, Anti-Cancer Agents in Med. Chem. 2018, 18, 2117.

(a) J. Schiebel, K. Kapilashrami, A. Fekete, G. R. Bommineni, C. M. Schaefer, M. J. Mueller, P. J. Tonge, C. Kisker, J. Biol. Chem. 2013, 288, 34190

(b) V. Singh, I. Mani, D. K. Chaudhary, P. Somvanshi, Curr. Med. Chem. 2011, 18, 1318.

(a) K. Kapilashrami, G. R. Bommineni, C. A. Machutta, P. Kim, C.-T. Lai, C. Simmerling, F. Picart, P. J. Tonge, J. Biol. Chem. 2013, 288, 6045

(b) S. R. Luckner, C. A. Machutta, P. J. Tonge, C. Kisker, Structure 2009, 17, 1004.

(a) Q. Al-Balas, N. G. Anthony, B. Al-Jaidi, A. Alnimr, G. Abbott, A. K. Brown, R. C. Taylor, G. S. Besra, T. D. McHugh, S. H. Gillespie, B. F. Johnston, S. P. Mackay, G. D. Coxon, PLOS One 2009, 4, e5617

(b) G. Pappenberger, T. Schulz-Gasch, E. Kusznir, F. Muller, M. Hennig, Acta Crystallogr., Sect. D: Biol. Crystallogr. 2007, 63, 1208.

Q. Shen, B. Zhang, R. Xu, Y. Wang, X. Ding, P. Li, Anaerobe 2010, 16, 380.

N. Balakrishnan, A. B. Panda, N. R. Raj, A. Shrivastava, R. Prathani, Asian J. Res. Chem. 2009, 2, 148.